{"total":1,"page":1,"pageSize":25,"pages":1,"millis":2,"query":{"q":"stay at home","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"","grade":"","collection":"","from":"","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-010","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-017 (DEA065), Dear Registrant letter on early refills and 90-day supplies of controlled substances during the COVID-19 emergency","title":"Early RX Refill (OMB 3-20-20)","dateIssued":"2020-03-20","startDate":"2020-03-20","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-010","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-010"}],"facets":{"kind":[{"value":"order","label":"Order","count":1}],"level":[{"value":"federal","label":"Federal","count":1}],"state":[],"type":[{"value":"HC","label":"Health care orders","count":1},{"value":"OTHER","label":"Other","count":1}],"quarter":[{"value":"2020Q2","label":"2020 Q2","count":1},{"value":"2020Q3","label":"2020 Q3","count":1},{"value":"2020Q4","label":"2020 Q4","count":1},{"value":"2021Q1","label":"2021 Q1","count":1},{"value":"2021Q2","label":"2021 Q2","count":1},{"value":"2021Q3","label":"2021 Q3","count":1}],"grade":[{"value":"primary","label":"Primary source read","count":1}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":1}]}}